People who experience psychosis may produce too much or even too little cannabinoids (from overactive dopamine receptors). CBD is milder than our internal cannabinoids and helps to re-establish a balance of cannabinoids in the brain. CBD also helps lower inflammation, which is often increased in schizophrenia. THC, on the other hand, is stronger than our internal cannabinoids (anandamide and 2-AG), this way potentially triggering psychosis [46, 48].
There are numerous wonderful resources on (but not restricted to) the web regarding CBD, the major phytocannabinoid which has added a whole extra dimension to cannabis-related studies, medication, and dietary supplementation. On the other hand, as is often the case with a novel matter, there is also a great deal of misinformation regarding its benefits.
As is the case with any plant that constitutes a crop, cannabis plants have been selectively bred over the years to bolster one or another desired characteristic. This means that some plants provide a more potent psychotropic effect, others possess more prominent seeds (used in the production of cooking oil traditionally), while others may make for sturdier textile fibers.